[1]
“Design of molecular inhibitors against the NuoC protein of Mycobacterium tuberculosis”, Int. J. Pharm. Sci. Drug Res., vol. 16, no. 3, pp. 308–322, May 2024, doi: 10.25004/IJPSDR.2024.160302.